These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37759223)

  • 21. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
    Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
    Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia.
    Wu N; Sarna LK; Siow YL; O K
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R635-43. PubMed ID: 21178122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY; Fedtsov A; Madias NE
    Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Simvastatin attenuated cardiac hypertrophy via inhibiting JAK-STAT pathways].
    Wu Y; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):738-43. PubMed ID: 19100119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway.
    Liu J; Shen Q; Wu Y
    Life Sci; 2008 May; 82(19-20):991-6. PubMed ID: 18400235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells.
    Jougasaki M; Ichiki T; Takenoshita Y; Setoguchi M
    Br J Pharmacol; 2010 Mar; 159(6):1294-303. PubMed ID: 20136831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
    Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
    Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
    Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
    J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation.
    White CM
    J Clin Pharmacol; 1999 Feb; 39(2):111-8. PubMed ID: 11563401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HMG-CoA reductase inhibitors: anti-atherosclerotic effects other than lipid-lowering].
    Fujita R; Matsushima T
    Nihon Rinsho; 1999 Dec; 57(12):2821-5. PubMed ID: 10638219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.
    Kita T; Brown MS; Goldstein JL
    J Clin Invest; 1980 Nov; 66(5):1094-100. PubMed ID: 6903572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
    Dichtl W; Dulak J; Frick M; Alber HF; Schwarzacher SP; Ares MP; Nilsson J; Pachinger O; Weidinger F
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):58-63. PubMed ID: 12524225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease.
    Järvisalo MJ; Toikka JO; Vasankari T; Mikkola J; Viikari JS; Hartiala JJ; Raitakari OT
    Atherosclerosis; 1999 Dec; 147(2):237-42. PubMed ID: 10559508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How do HMG-CoA reductase inhibitors prevent stroke?
    Bedi A; Flaker GC
    Am J Cardiovasc Drugs; 2002; 2(1):7-14. PubMed ID: 14727994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.
    Bustos C; Hernández-Presa MA; Ortego M; Tuñón J; Ortega L; Pérez F; Díaz C; Hernández G; Egido J
    J Am Coll Cardiol; 1998 Dec; 32(7):2057-64. PubMed ID: 9857893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase.
    Cao Z; Fan-Minogue H; Bellovin DI; Yevtodiyenko A; Arzeno J; Yang Q; Gambhir SS; Felsher DW
    Cancer Res; 2011 Mar; 71(6):2286-97. PubMed ID: 21262914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lovastatin treatment inhibits sterol synthesis and induces HMG-CoA reductase activity in mononuclear leukocytes of normal subjects.
    Stone BG; Evans CD; Prigge WF; Duane WC; Gebhard RL
    J Lipid Res; 1989 Dec; 30(12):1943-52. PubMed ID: 2621421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.